Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Cash: 2015-2025

Historic Change in Cash for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to -$12.3 million.

  • Wave Life Sciences' Change in Cash fell 107.80% to -$12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.7 million, marking a year-over-year decrease of 167.04%. This contributed to the annual value of $101.8 million for FY2024, which is 9.03% down from last year.
  • As of Q3 2025, Wave Life Sciences' Change in Cash stood at -$12.3 million, which was up 64.57% from -$34.6 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Change in Cash registered a high of $157.0 million during Q3 2024, and its lowest value of -$88.9 million during Q1 2022.
  • For the 3-year period, Wave Life Sciences' Change in Cash averaged around $9.8 million, with its median value being -$19.4 million (2024).
  • Per our database at Business Quant, Wave Life Sciences' Change in Cash soared by 1,408.84% in 2022 and then plummeted by 203.87% in 2025.
  • Wave Life Sciences' Change in Cash (Quarterly) stood at $26.7 million in 2021, then tumbled by 131.69% to -$8.5 million in 2022, then spiked by 815.00% to $60.4 million in 2023, then plummeted by 114.66% to -$8.9 million in 2024, then plummeted by 107.80% to -$12.3 million in 2025.
  • Its Change in Cash was -$12.3 million in Q3 2025, compared to -$34.6 million in Q2 2025 and -$59.0 million in Q1 2025.